Fuso Pharmaceutical Industries: 1st quarter financial statement for March 2025 (Japan standard) (non-consolidated).
Fuso Pharmaceutical Industries: Interim report
Fuso Pharmaceutical Industries: Confirmation letter
Fuso Pharmaceutical Industries: Securities Report - 101st Fiscal Year (April 1, 2023 - March 31, 2024)
Fuso Pharmaceutical Industries: Extraordinary Report
Fuso Pharmaceutical Industries: Summary of financial results for the fiscal year ending 2024/3 [Japanese GAAP] (unconsolidated)
Fuso Pharmaceutical Industries: Extraordinary Report
Fuso Pharmaceutical Industries: Confirmation
Fuso Pharmaceutical Industries: Quarterly Report - 101st Term 3rd Quarter (2023/10/01 - 2023/12/31)
Fuso Pharmaceutical Industries: Summary of financial results for the 3rd quarter of the fiscal year ending 2024/3 [Japanese GAAP] (unconsolidated)
Fuso Pharmaceutical Industries: Confirmation letter
Fuso Pharmaceutical Industries: Quarterly Report - The 101st Second Quarter (2023/07/01 - 2023/09/30)
Fuso Pharmaceutical Industries: Summary of financial results for the 2nd quarter of the fiscal year ending March 31, 2024 [Japanese GAAP] (unconsolidated)
Fuso Pharmaceutical Industries: Extraordinary Report
Fuso Pharmaceutical Industries: Confirmation letter
Fuso Pharmaceutical Industries: Quarterly Report - 101st Quarter (2023/04/01 - 2023/06/30)
Fuso Pharmaceutical Industries: Summary of Financial Results for the 1st Quarter of the Fiscal Year Ending March 31, 2024 [Japanese GAAP] (Unconsolidated)
Fuso Pharmaceutical Industries: Extraordinary Report
Fuso Pharmaceutical Industries: Confirmation letter
Fuso Pharmaceutical Industries: Securities Report - 100th Period (2022/04/01 - 2023/03/31)
No Data
No Data